{"id":"W4402565845","doi":"10.1016/j.annonc.2024.08.2325","title":"LBA82 Efficacy and safety of ponsegromab, a first-in-class, monoclonal antibody inhibitor of growth differentiation factor 15, in patients with cancer cachexia: A randomized, placebo-controlled, phase II study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Monoclonal antibody; Cachexia; Placebo; Oncology; Cancer cachexia; Internal medicine; Monoclonal; Randomized controlled trial; Phases of clinical research; Cancer; Antibody; Clinical trial; Immunology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001092859,0.00139824,0.002697478,0.0004524502,0.0003997396,0.0009157015,0.0007961042,0.001552562,0.004022136],"category_scores_gemma":[0.0008925675,0.0006601473,0.001508133,0.0004106945,0.001227368,0.0008632598,0.0002832418,0.002756616,0.0008448283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006267342,"about_ca_system_score_gemma":0.0009338612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008219473,"about_ca_topic_score_gemma":0.001829157,"domain_scores_codex":[0.9996588,0.0001509144,0.00001770376,0.00005882308,0.00003504282,0.0000786319],"domain_scores_gemma":[0.9994488,0.0001408184,0.000112713,0.00004216539,0.00003590933,0.0002195928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9359584,0.01813235,0.001296383,0.0005394524,0.001342661,0.00005886218,0.00005278223,0.0004903631,0.01146122,0.0001125293,0.0009989426,0.02955598],"study_design_scores_gemma":[0.8146902,0.1776106,0.004391482,0.00002614426,0.0006906991,0.00005576554,0.00002667207,0.0004767194,0.001069075,0.0001053274,0.0008375844,0.00001959441],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919429,0.003920389,0.0003528864,0.0003843325,0.0001913519,0.0008661529,0.0006733391,0.0001117991,0.001556854],"genre_scores_gemma":[0.9924682,0.002055897,0.0005635289,0.0006944867,0.000255919,0.0008468054,0.001068652,0.00002130842,0.002025123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004022136,"threshold_uncertainty_score":0.01345545,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01770669949229705,"score_gpt":0.339244890681104,"score_spread":0.3215381911888069,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}